From: Processes to manage analyses and publications in a phase III multicenter randomized clinical trial
Journal names | Number of publications | Number of unique first authors | 2012 impact factor |
---|---|---|---|
1. New England Journal of Medicine | 1 | 1 | 53.30 |
2. Gastroenterology | 14 | 10 | 11.68 |
3. Hepatology | 21 | 14 | 11.67 |
4. Gut | 1 | 1 | 10.11 |
5. Journal of Hepatology | 4 | 4 | 9.26 |
6. American Journal of Gastroenterology | 6 | 3 | 7.28 |
7. Journal of Infectious Diseases | 1 | 1 | 6.41 |
8. Clinical Gastroenterology Hepatology | 4 | 4 | 5.63 |
9. Gastrointestinal Endoscopy | 1 | 1 | 4.88 |
10. Journal of Clinical Microbiology | 1 | 1 | 4.15 |
11. PLoS One | 3 | 3 | 4.09 |
12. Journal of Viral Hepatitis | 2 | 2 | 4.09 |
13. Liver International | 1 | 1 | 3.82 |
14. Alimentary Pharmacology Therapeutics | 5 | 3 | 3.77 |
15. J Affect Disorders | 1 | 1 | 3.52 |
16. Pharmacogenetics and Genomics | 1 | 1 | 3.49 |
17. Journal of International Neuropsychology Society | 1 | 1 | 2.76 |
18. Clinical Trials | 1 | 1 | 2.36 |
19. Virology Journal | 1 | 1 | 2.34 |
20. Journal of Clinical Experimental Neuropsychology | 1 | 1 | 2.13 |
21. Psychosomatics | 1 | 1 | 2.12 |
22. Digestive Disease Sciences | 1 | 1 | 2.12 |
23. Contemporary Clinical Trials | 1 | 1 | 1.81 |
TOTAL | 74 | Â | Â |